Naghmeh Khodai
Obstetrics & Gynecology · Calabasas, CANPI 1457519803
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.8% of the total across 246 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 32 manufacturers reported payments, led by AbbVie at 36.6% of the total. Reporting peaked in 2022 at $753 and has fallen 68.4% since, to $238 in 2025.
Across 246 payments — averaging $12.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Pfizer$431
- Sumitomo Pharma America, Inc.$227
- Mayne Pharma Commercial LLC$222
- Myovant Sciences Inc.$124
- Organon$118
- plus $873 from 26 others
Across 1 payment — averaging $6400.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Organon$6K
What the payments were for
- Food & beverage$3,10699%
- Education$371%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 126 | $1,149 |
| Pfizer | 23 | $431 |
| Sumitomo Pharma America, Inc. | 25 | $227 |
| Mayne Pharma Commercial LLC | 15 | $222 |
| Myovant Sciences Inc. | 8 | $124 |
| Organon | 5 | $118 |
| Hologic Sales And Service, LLC | 5 | $99 |
| Exeltis, USA Inc. | 5 | $97 |
| Sage Therapeutics, LLC | 5 | $86 |
| Agile Therapeutics, Inc. | 4 | $69 |
| Shield Therapeutics Inc | 2 | $41 |
| AMAG Pharmaceuticals, Inc. | 2 | $37 |
| Therapeuticsmd, Inc. | 2 | $37 |
| Myriad Women's Health, Inc. | 1 | $35 |
| Astellas Pharma US Inc | 1 | $33 |
| Dutch Ophthalmic, USA | 1 | $33 |
| Scynexis, Inc. | 1 | $29 |
| Meditrina | 1 | $25 |
| Bayer | 1 | $24 |
| Millicent US Inc | 1 | $23 |
| Novo Nordisk | 1 | $22 |
| Merck | 1 | $22 |
| Duchesnay USA Incorporated | 1 | $22 |
| Avion Pharmaceuticals | 1 | $21 |
| Mycovia Pharmaceuticals, Inc. | 1 | $20 |
| Exact Sciences | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Evofem Biosciences, Inc. | 1 | $14 |
| Zyla Life Sciences, Inc. | 1 | $14 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
| Aspira Women's Health Inc | 1 | $13 |
| Medicem Inc. | 1 | $12 |
How this compares
$3,144 in reported general payments places this provider in the 80th percentile of 3,784 obstetrics & gynecology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 38 | $3,342 |
| Estradiol (Twice Weekly)Estradiol | 14 | $1,666 |
| ProgesteroneProgesterone, Micronized | 24 | $686 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 40 | $587 |
| ValacyclovirValacyclovir Hcl | 18 | $529 |
| Medroxyprogesterone Acetate | 11 | $283 |
| Fluconazole | 17 | $70 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Calabasas
- Steve YuNorthridge$964K
- Samir HageRedlands$640K
- Malcolm MunroLos Angeles$609K
- Michael KrychmanCosta Mesa$547K
- Anita NelsonTorrance$530K
- Jan SegnitzSan Jose$511K
- Risa KaganBerkeley$497K
- Michael GreenOxnard$424K
- Howard SalvaySanta Cruz$421K
- Marc WinterLaguna Hills$399K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.